Sex differences in the associations of water, coffee and tea consumption with cardiovascular diseases: a prospective cohort study
Frontiers in Nutrition · 30.01.2025 · 12
DOI: 10.3389/fnut.2025.1530908 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Nutrition, online erschienen am 30.01.2025. Verfasst von Dandan Ke und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Water, coffee and tea are the primary sources of daily hydration. However, the sex-specific relationship between these beverages and cardiovascular disease (CVD) among remains unclear.
Methods
In total, 210,239 men and 251,383 women from the UK Biobank were included. The consumption of water, coffee and tea were self-reported. CVDs, including coronary heart disease (CHD), stroke and heart failure (HF) were followed till March 1st, 2023. Sex-specific Cox models were utilized to evaluate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations.
Results
During a median follow-up of 8.7 years, 11,098 (2.40%) participants developed new-onset HF, 33,426 (7.24%) participants developed new-onset CHD, and 9,706 (2.10%) participants developed new-onset stroke. After adjustments, higher water consumption was generally associated with reduced risk of CVDs among both men and women. In contrast, heavy coffee consumption (particularly ≥6 cups/day) was associated with a greater risk of HF [1.16 (1.03–1.31) in men vs. 1.25 (1.12–1.40) in women], a greater risk of CHD [1.27 (1.18–1.36) in men vs. 1.21 (1.14–1.29) in women] and a greater risk of stroke [1.13 (0.99–1.29) in men vs. 1.20 (1.03–1.31) in women]. Similarly, heavy tea consumption was associated with an increased risk of HF (men: HR 1.19 [1.08–1.31]; women: HR 1.12 [1.02–1.23]) and CHD (men: HR 1.12 [1.05–1.18]; women: HR 1.18 [1.12–1.24]).
Conclusion
Our study revealed that water consumption was associated with a lower risk of CVDs, with a lower risk of CVDs, while heavy coffee or tea consumption was linked to a higher risk. Notably, coffee and tea consumption partially attenuated the protective association of water intake with CVDs. Furthermore, significant sex differences were observed in the associations between coffee or tea consumption and CHD incidence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- School of Humanities and Social Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Medical Information Technology and Management, Yanjing Medical College, Capital Medical University, Beijing, China.
- Department of Bioinformatics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Zitieren
APA
Ke, D., Wang, Y., Hou, Y., Shao, W., Ke, J., Zhang, X., Yang, H., He, Z., & Lu, Z. (2025). Sex differences in the associations of water, coffee and tea consumption with cardiovascular diseases: a prospective cohort study. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1530908
Vancouver
Ke D, Wang Y, Hou Y, Shao W, Ke J, Zhang X, et al. Sex differences in the associations of water, coffee and tea consumption with cardiovascular diseases: a prospective cohort study. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1530908
BibTeX
@article{Ke2025,
author = {Ke, Dandan and Wang, Yueqing and Hou, Yabing and Shao, Weihao and Ke, Jiawen and Zhang, Xiaoxuan and Yang, Hongxi and He, Zhong and Lu, Zuolin},
title = {Sex differences in the associations of water, coffee and tea consumption with cardiovascular diseases: a prospective cohort study},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1530908}
}
EUVIMED